Merit Medical Systems, Inc. (MMSI)
NASDAQ: MMSI · Real-Time Price · USD
66.74
-0.69 (-1.02%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Merit Medical Systems Revenue
In the year 2025, Merit Medical Systems had annual revenue of $1.52B with 11.75% growth. Merit Medical Systems had revenue of $393.94M in the quarter ending December 31, 2025, with 10.92% growth.
Revenue (ttm)
$1.52B
Revenue Growth
+11.75%
P/S Ratio
2.63
Revenue / Employee
$202,121
Employees
7,500
Market Cap
3.98B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.52B | 159.39M | 11.75% |
| Dec 31, 2024 | 1.36B | 99.15M | 7.89% |
| Dec 31, 2023 | 1.26B | 106.39M | 9.24% |
| Dec 31, 2022 | 1.15B | 76.23M | 7.09% |
| Dec 31, 2021 | 1.07B | 110.88M | 11.50% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Avantor | 6.55B |
| Bausch + Lomb | 5.10B |
| DENTSPLY SIRONA | 3.68B |
| MiniMed Group | 2.99B |
| Envista Holdings | 2.72B |
| ICU Medical | 2.23B |
| Teleflex | 1.99B |
| Stevanato Group | 1.39B |
MMSI News
- 5 weeks ago - Medtronic and Merit Medical Systems enter into agreement to offer new, FDA-cleared ViaVerte™ system, a basivertebral nerve ablation treatment for chronic vertebrogenic lower-back pain - PRNewsWire
- 6 weeks ago - Merit Medical Launches the Resilience Through-the-Scope Esophageal Stent - GlobeNewsWire
- 2 months ago - Merit Medical Systems Earnings Call Transcript: Q4 2025 - Transcripts
- 3 months ago - Merit Medical Systems Transcript: 44th Annual J.P. Morgan Healthcare Conference - Transcripts
- 3 months ago - Merit Medical Appoints F. Ann Millner as Chair of the Board and Announces Projected Preliminary Unaudited Revenue Results for the Fourth Quarter of 2025 - GlobeNewsWire
- 5 months ago - Merit Medical Systems Transcript: Piper Sandler 37th Annual Healthcare Conference - Transcripts
- 6 months ago - Merit Medical Releases 24-Month Efficacy Results from the Single-Arm Arteriovenous Graft (AVG) Cohort of the WRAPSODY Arteriovenous Access Efficacy (WAVE) Trial - GlobeNewsWire
- 6 months ago - Merit Medical Systems Earnings Call Transcript: Q3 2025 - Transcripts